文献速递外周动脉疾病

心力衰竭对慢性肢体威胁性缺血患者腹股沟下血运重建后临床结局的影响

Influence of heart failure on the clinical outcomes of patients with chronic limb-threatening ischemia after infrainguinal revascularization.
PubMed 文献 · J Vasc Surg · 2025-04-11

这项多中心回顾性研究分析了2015至2022年间因慢性肢体威胁性缺血(CLTI)接受腹股沟下血运重建的772例患者,其中心力衰竭(HF)患者186例(24%)。HF组2年无截肢生存率(AFS)为63%±2%,非HF组为50%±4%(P<.01);HF组中旁路手术组AFS显著高于腔内治疗(EVT)组(59%±7% vs 46%±5%;P=.04)。HF是AFS的稳健负性预测因子,射血分数降低的心力衰竭(HFrEF)也是AFS的负性预测因子。

要点

  • HF患者2年AFS为63%±2%,非HF组为50%±4%(P<.01)。
  • HF组中旁路手术AFS为59%±7%,EVT组为46%±5%(P=.04)。
  • HFpEF、HFmrEF、HFrEF组AFS分别为61%±6%、50%±8%、35%±7%(P<.01)。

核心结论

  • HF是接受腹股沟下血运重建的CLTI患者AFS的稳健负性预测因子。
  • HFrEF是AFS的负性预测因子。

研究设计与样本

  • 多中心回顾性分析2015至2022年间因CLTI接受腹股沟下血运重建的患者。
  • 共纳入772例患者,其中186例(24%)患有HF。

主要发现

  • HF组与非HF组在WIfI分期、GLASS分期或治疗方式上无差异。
  • HF组2年AFS为63%±2%,非HF组为50%±4%(P<.01)。
  • HF组中旁路手术组AFS为59%±7%,EVT组为46%±5%(P=.04)。
  • HFpEF、HFmrEF、HFrEF组AFS分别为61%±6%、50%±8%、35%±7%(P<.01)。
  • 全部患者中AFS的负性预测因子包括年龄≥80岁、非行走状态、低白蛋白血症(<3.5 g/dL)、终末期肾病、EVT、WIfI分期4期和HF。

关键数值与推荐

  • HFrEF定义为EF<40%,HFmrEF定义为40%≤EF<50%,HFpEF定义为EF≥50%。
  • HF组中AFS的显著负性预测因子包括年龄≥80岁、非行走状态、EVT、WIfI分期4期和EF降低(<40%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We examined the influence of heart failure (HF) on patients with chronic limb-threatening ischemia (CLTI) and the negative predictors of limb and life prognosis among patients with CLTI and HF, the clinical outcomes of patients with CLTI after infrainguinal revascularization were compared. METHODS: Multicenter data of patients who underwent infrainguinal revascularization for CLTI between 2015 and 2022 were analyzed retrospectively. The end point was amputation-free survival (AFS) among patients with HF or without HF. Subgroup analyses among patients with HF were performed grouped by revascularization procedures or ejection fraction (EF) classification: HF with reduced EF (HFrEF) (EF of <40%), HF with mildly reduced EF (HFmrEF) (40% ≤ EF < 50%), and HF with preserved EF (HFpEF) (EF ≥50%). RESULTS: Of the 772 patients included, 186 (24%) had HF. No differences were found in the Wound, Ischemia, foot Infection (WIfI) stage, Global Limb Anatomic Staging System stage, or treatment procedures between the HF and non-HF groups. The 2-year AFS rates of the HF and non-HF groups were 63% ± 2% vs 50% ± 4%, respectively (P < .01). Among the HF group, the AFS of the bypass group was significantly higher than that of the endovascular therapy (EVT) group (59% ± 7% vs 46% ± 5%; P = .04). Then, the AFS rates of the HFpEF, HFmrEF, and HFrEF groups were 61% ± 6%, 50% ± 8%, and 35% ± 7%, respectively (P < .01). Multivariate Cox proportional hazard analyses identified age ≥80 years, nonambulatory status, hypoalbuminemia (<3.5 g/dL), end-stage renal disease, EVT, WIfI stage 4, and HF as negative predictors of AFS among all patients. In the HF group, age ≥80 years, nonambulatory status, EVT, WIfI stage 4, and reduced EF (<40%) were significant negative predictors. CONCLUSIONS: HF is a robust negative predictor of AFS among patients with CLTI who underwent infrainguinal revascularization. HFrEF was a negative predictor of AFS.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Inoue K, Morisaki K, Matsuda D, et al. Influence of heart failure on the clinical outcomes of patients with chronic limb-threatening ischemia after infrainguinal revascularization. J Vasc Surg. 2025. PMID: 40220974. doi:10.1016/j.jvs.2025.04.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。